{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:41:40Z","timestamp":1792737700518,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","award":["2023WW103"],"award-info":[{"award-number":["2023WW103"]}],"id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271973"],"award-info":[{"award-number":["82271973"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91959118"],"award-info":[{"award-number":["91959118"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015956","name":"Special Project for Research and Development in Key areas of Guangdong Province","doi-asserted-by":"publisher","award":["2019B020235002"],"award-info":[{"award-number":["2019B020235002"]}],"id":[{"id":"10.13039\/501100015956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515010582"],"award-info":[{"award-number":["2021A1515010582"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejrad.2026.113240","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:09:49Z","timestamp":1789085389000},"page":"113240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["MR Elastography-based stiffness as a marker for predicting hepatocellular carcinoma refractory to transarterial chemoembolization"],"prefix":"10.1016","volume":"205","author":[{"given":"Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zebin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haimei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Ehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7956-9579","authenticated-orcid":false,"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejrad.2026.113240_b0005","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.ejrad.2026.113240_b0010","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jhep.2019.08.017","article-title":"Advances in molecular classification and precision oncology in hepatocellular carcinoma","volume":"72","author":"Rebouissou","year":"2020","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.ejrad.2026.113240_b0015","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.ejrad.2026.113240_b0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL clinical practice guidelines on the management of hepatocellular carcinoma","volume":"82","author":"Sangro","year":"2025","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.ejrad.2026.113240_b0025","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol. Int."},{"issue":"1","key":"10.1016\/j.ejrad.2026.113240_b0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000530950","article-title":"Radiologic patterns determine the outcomes of initial and subsequent transarterial chemoembolization in intermediate-stage hepatocellular carcinoma","volume":"13","author":"Hung","year":"2024","journal-title":"Liver Cancer"},{"issue":"3","key":"10.1016\/j.ejrad.2026.113240_b0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000507370","article-title":"A changing paradigm for the treatment of intermediate-stage hepatocellular carcinoma: Asia-pacific primary liver cancer expert consensus statements","volume":"9","author":"Kudo","year":"2020","journal-title":"Liver Cancer"},{"issue":"5","key":"10.1016\/j.ejrad.2026.113240_b0040","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jvir.2022.02.005","article-title":"Survival analysis using albumin-bilirubin (ALBI) grade for patients treated with drug-eluting embolic transarterial chemoembolization for hepatocellular carcinoma","volume":"33","author":"Young","year":"2022","journal-title":"J. Vasc. Interv. Radiol."},{"key":"10.1016\/j.ejrad.2026.113240_b0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ctrv.2018.11.002","article-title":"Updated use of TACE for hepatocellular carcinoma treatment: how and when to use it based on clinical evidence","volume":"72","author":"Raoul","year":"2019","journal-title":"Cancer Treat. Rev."},{"issue":"2","key":"10.1016\/j.ejrad.2026.113240_b0050","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3748\/wjg.v27.i2.189","article-title":"Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma","volume":"27","author":"Niu","year":"2021","journal-title":"World J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.ejrad.2026.113240_b0055","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1177\/0284185120971844","article-title":"Prediction of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma using imaging features of gadoxetic acid-enhanced magnetic resonance imaging","volume":"62","author":"Byun","year":"2021","journal-title":"Acta Radiol."},{"issue":"1","key":"10.1016\/j.ejrad.2026.113240_b0060","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12880-022-00900-8","article-title":"Preoperatively predicting early response of HCC to TACE using clinical indicators and MRI features","volume":"22","author":"Li","year":"2022","journal-title":"BMC Med. Imaging"},{"issue":"6","key":"10.1016\/j.ejrad.2026.113240_b0065","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.21037\/qims-22-292","article-title":"The course and prognostic value of tumor stiffness detected by ultrasound elastography for transarterial chemoembolization of hepatocellular carcinoma","volume":"13","author":"Hou","year":"2023","journal-title":"Quant. Imaging Med. Surg."},{"issue":"12","key":"10.1016\/j.ejrad.2026.113240_b0070","doi-asserted-by":"crossref","first-page":"9468","DOI":"10.1007\/s00330-021-08053-y","article-title":"Comparison of the diagnostic performance of 2D and 3D MR elastography in staging liver fibrosis","volume":"31","author":"Li","year":"2021","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2026.113240_b0075","doi-asserted-by":"crossref","unstructured":"R. Catania, C. Lopes Vendrami, B.D. Bolster, R. Niemzcura, A.A. Borhani, F.H. Miller, Intra-patient comparison of 3D and 2D magnetic resonance elastography techniques for assessment of liver stiffness, Abdom Radiol (NY) 47(3) (2022) 998-1008, doi: 10.1007\/s00261-021-03355-7.","DOI":"10.1007\/s00261-021-03355-7"},{"issue":"6","key":"10.1016\/j.ejrad.2026.113240_b0080","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1007\/s00330-022-09290-5","article-title":"The value of quantitative MR elastography-based stiffness for assessing the microvascular invasion grade in hepatocellular carcinoma","volume":"33","author":"Zhang","year":"2023","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2026.113240_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2022.110340","article-title":"MR elastography as a biomarker for prediction of early and late recurrence in HBV-related hepatocellular carcinoma patients before hepatectomy","volume":"152","author":"Zhang","year":"2022","journal-title":"Eur. J. Radiol."},{"issue":"1","key":"10.1016\/j.ejrad.2026.113240_b0090","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s40425-019-0766-y","article-title":"Immunotherapy response evaluation with magnetic resonance elastography (MRE) in advanced HCC","volume":"7","author":"Qayyum","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.ejrad.2026.113240_b0095","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/jmri.26250","article-title":"3D MR Elastography of hepatocellular carcinomas as a potential biomarker for predicting tumor recurrence","volume":"49","author":"Wang","year":"2019","journal-title":"J. Magn. Reson. Imaging"},{"issue":"6","key":"10.1016\/j.ejrad.2026.113240_b0100","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1002\/jmri.29276","article-title":"Three-dimensional multifrequency MR Elastography for microvascular invasion and prognosis assessment in hepatocellular carcinoma","volume":"60","author":"Liu","year":"2024","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.ejrad.2026.113240_b0105","article-title":"Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus immunotherapy and targeted therapy in HCC (CHANCE2204)","author":"Jin","year":"2025","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.ejrad.2026.113240_b0110","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1148\/radiol.15142394","article-title":"Single hepatocellular carcinoma: Preoperative MR imaging to predict early recurrence after curative resection","volume":"276","author":"An","year":"2015","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.ejrad.2026.113240_b0115","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jhep.2017.04.024","article-title":"Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma","volume":"67","author":"Lee","year":"2017","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.ejrad.2026.113240_b0120","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.233229","article-title":"Gadoxetic acid-enhanced MRI scoring model to predict pathologic features of hepatocellular carcinoma","volume":"314","author":"Zhang","year":"2025","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.ejrad.2026.113240_b0125","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1148\/radiol.2018181494","article-title":"Liver imaging reporting and data system (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients","volume":"289","author":"Chernyak","year":"2018","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.ejrad.2026.113240_b0130","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.221835","article-title":"VICT2 Trait: Prognostic alternative to peritumoral hepatobiliary phase hypointensity in HCC","volume":"307","author":"Jiang","year":"2023","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.ejrad.2026.113240_b0135","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1159\/000530441","article-title":"Transcatheter arterial chemoembolization for treatment-naive hepatocellular carcinoma has different treatment effects depending on central or peripheral tumor location","volume":"12","author":"Asano","year":"2023","journal-title":"Liver Cancer"},{"key":"10.1016\/j.ejrad.2026.113240_b0140","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.2147\/JHC.S480554","article-title":"Tumor growth pattern and intra- and peritumoral radiomics combined for prediction of initial TACE outcome in patients with primary hepatocellular carcinoma","volume":"11","author":"Li","year":"2024","journal-title":"J Hepatocell Carcinoma"},{"issue":"8","key":"10.1016\/j.ejrad.2026.113240_b0145","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1007\/s00330-025-11375-w","article-title":"Three-dimensional MR elastography-based stiffness for assessing the status of Ki67 proliferation index and Cytokeratin-19 in hepatocellular carcinoma","volume":"35","author":"Zhang","year":"2025","journal-title":"Eur. Radiol."},{"issue":"3","key":"10.1016\/j.ejrad.2026.113240_b0150","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/jcb.27681","article-title":"Extracellular matrix (ECM) stiffness and degradation as cancer drivers","volume":"120","author":"Najafi","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"18","key":"10.1016\/j.ejrad.2026.113240_b0155","doi-asserted-by":"crossref","first-page":"20214","DOI":"10.1021\/acsami.0c03022","article-title":"Mild Acid-Responsive \u201cNanoenzyme Capsule\u201d Remodeling of the Tumor microenvironment to increase tumor penetration","volume":"12","author":"Yao","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"2","key":"10.1016\/j.ejrad.2026.113240_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188356","article-title":"Fibrosis and cancer: a strained relationship","volume":"1873","author":"Piersma","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"7","key":"10.1016\/j.ejrad.2026.113240_b0165","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00432-024-05864-6","article-title":"Relaxin combined with transarterial chemoembolization achieved synergistic effects and inhibited liver cancer metastasis in a rabbit VX2 model","volume":"150","author":"Wang","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"15","key":"10.1016\/j.ejrad.2026.113240_b0170","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.3748\/wjg.v20.i15.4128","article-title":"Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma","volume":"20","author":"Rani","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"21","key":"10.1016\/j.ejrad.2026.113240_b0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218165","article-title":"Recent updates of transarterial chemoembolilzation in hepatocellular carcinoma","volume":"21","author":"Chang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejrad.2026.113240_b0180","doi-asserted-by":"crossref","unstructured":"T. Garg, A. Shrigiriwar, P. Habibollahi, M. Cristescu, R.P. Liddell, J. Chapiro, P. Inglis, J.C. Camacho, N. Nezami, Intraarterial therapies for the management of hepatocellular carcinoma, Cancers (Basel) 14(14) (2022) 3351, doi: 10.3390\/cancers14143351.","DOI":"10.3390\/cancers14143351"},{"issue":"6","key":"10.1016\/j.ejrad.2026.113240_b0185","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1148\/rg.220022","article-title":"Local-regional treatment of hepatocellular carcinoma: a primer for radiologists","volume":"42","author":"Horvat","year":"2022","journal-title":"Radiographics"}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X26005887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X26005887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:35:55Z","timestamp":1792737355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X26005887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":37,"alternative-id":["S0720048X26005887"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2026.113240","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MR Elastography-based stiffness as a marker for predicting hepatocellular carcinoma refractory to transarterial chemoembolization","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2026.113240","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113240"}}